European Urology Open Science (Jul 2020)

Can combination of OAB medication and intravesical botulinum toxin A prolong the therapeutic duration and effect in patients with overactive bladder syndrome

  • C.C. Wang,
  • C.L. Lee,
  • H.C. Kuo

Journal volume & issue
Vol. 19
pp. e805 – e806

Abstract

Read online

No abstracts available.